In addition, the increased expression of CD39 on cytotoxic T-cell induced by MDSCs correlated with poor prognosis in advanced NSCLC patients treated with anti-PD-1 mAbs (66). This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.